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Amyotrophic lateral sclerosis (ALS) and prionopathies, such as Creutzfeldt-Jakob disease 
(CJD), are devastating neurodegenerative diseases with a relatively early age of onset and a 
rapid disease course. Prior to 1983, slowly progressing dementia with motor neuron signs 
was often considered part of the CJD spectrum, termed the “amyotrophic form” of CJD [4]. 
The landmark study by Salazar and colleagues demonstrated that “amyotrophic CJD” was 
not a transmissible form of CJD, but was more akin to classic ALS [7], with the spongiosis 
noted in such cases now recognized as a nonspecific feature of frontotemporal degenerations 
[1]. While 27 cases with amyotrophy and prion disease have been reported, only 4 have had 
immunohistochemical proof of prion disease, while 7 had anterior horn cell pathology 
without mention of evidence of upper motor neuron pathology [8]. Moreover, none had 
immunohistochemistry with the molecular pathologic marker of ALS, TAR DNA-binding 
protein of 43 kDa (TDP-43), which labels neuronal and glial inclusions in ALS [5]. In 2008, 
a novel human prion disease was discovered by Gambetti and colleagues characterized by 
variable sensitivity of prion protein to protease digestion [2]. Named “variably protease-
sensitive prionopathy” (VPSPr), the clinical presentation, age of onset, and disease duration 
as well as the histopathology of this disorder differed between PRNP genetic variants 
(129V/V, 129M/V, 129M/M) and from CJD [3, 9].
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We report a 74-year-old woman followed longitudinally as part of prospective studies of 
dementia with Lewy bodies at Mayo Clinic who had a one-year history of gradually 
progressive dementia, cognitive fluctuations, excessive daytime sleepiness, visual 
hallucinations, and probable rapid eye movement sleep behavior disorder. General motor 
exam revealed normal strength and muscle tone. Magnetic resonance imaging indicated mild 
generalized cortical atrophy. By age 75, she developed agitation, behavioral disturbances, 
incontinence, and struggles with activities-of-daily-living. A year later, she had dysarthria, 
and difficulty ambulating, with stooped posture, shuffling, and unsteady gait. By age 77, she 
had dysphagia and was wheelchair bound and unresponsive. She died at the age of 78.
Macroscopic examination of the fixed left hemibrain revealed diffuse cortical atrophy, 
enlargement of lateral ventricles, and thinning of the cortical ribbon. The hippocampus and 
amygdala were atrophic, but the basal ganglia and thalamus were unremarkable. There was 
visible pigmentation in the substantia nigra, but pallor of the locus ceruleus.
Microscopic examination showed spongiform change and gliosis throughout the neocortex 
with ballooned neurons (Fig. 1a). Spongiform change was also noted in the hippocampus, 
basal ganglia (Fig. 1b), and minimally in the thalamus. Purkinje cell loss and Bergmann 
gliosis was seen in the cerebellum, and was associated with dense-cored plaques with 
thioflavin S fluorescent microscopy. In addition, skein-like inclusions, hyaline inclusions, 
and Bunina bodies were observed (Fig. 1c). Prion protein (PrP) immunohistochemistry (3F4 
antibody; 1:50,000) revealed many plaque-like lesions and coarse granular 
immunoreactivity in the neocortex (Fig. 1d), dentate fascia, amygdala, and basal ganglia, 
with small dense plaques in the cerebellum (Fig. 1e). PrP pathology and spongiform change 
was uniform in severity across the neocortex. Immunohistochemistry for TDP-43 (MC2085 
antibody; 1:2,500), a neuropathologic hallmark of ALS, revealed neuronal cytoplasmic 
inclusions in residual Betz cells, as well as skein-like and Lewy-like hyaline inclusions in 
the hypoglossal nucleus (Fig. 1g). No additional white matter TDP-43 pathology or 
extramotor TDP-43 pathology was detected. Marked neuronal cell loss of anterior horn cells 
was observed in the cervical spinal cord in addition to the aforementioned TDP-43 
immunoreactive lesions (Fig. 1h). There was mild demyelination and microglial activation 
in the pyramidal tract with Luxol fast blue for myelin and IBA-1 immunohistochemistry 
(1:3000) for microglia (data not shown). Together, these findings were consistent with lower 
motor neuron predominant ALS. No Lewy bodies or Lewy neurites were detected by α-
synuclein immunohistochemistry. There were no neurofibrillary tangles or amyloid 
angiopathy on thioflavin-S fluorescent microscopy. Many diffuse, non-neuritic senile 
plaques were seen throughout the neocortex on thioflavin-S microscopy as well as in the 
hippocampus with Aβ immunohistochemistry (33.1.1 antibody; 1:1,000). C9RANT 
immunohistochemistry (Rb5823 antibody; 1:5,000), a specific marker of the C9ORF72 
hexanucleotide repeat expansion, was negative. Ultrastructural analysis confirmed 
spongiform change and PrP-positive plaques in the hippocampus (Fig. 1f) as well as skein-
like inclusions in motor neurons composed of TDP-43-positive ~10-nm diameter granule-
coated filaments (Fig. 1i).
Brain homogenates were prepared in LB100 lysis buffer, treated with 2 U/ml of proteinase 
K for 1 hour at 37°C, and run on 15% Tris/glycine SDS-polyacrylamide gels [6]. Western 
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blot examination (with 3F4 and 1E4 antibodies) demonstrated a PrP five band ladder profile 
consistent with VPSPr compared to the three band profile of sporadic CJD (Fig. 2) [2, 9]. 
Sequencing of PRNP failed to detect pathogenic mutations and demonstrated methionine/
valine heterozygosity at codon 129 [9]. These results led to the final neuropathologic 
diagnosis of coincident VPSPr and ALS.
The comorbidity of prion disease and ALS is exceedingly rare, but may be more likely with 
VPSPr given the later disease-onset and longer disease duration compared to typical CJD. 
Initial clinical features consistent with dementia with Lewy bodies in this patient were likely 
related to VPSPr since there was no extramotor TDP-43 pathology. Later gait disturbances 
and dysphagia were probably due to ALS involvement of motor tracts and motor neurons in 
spinal cord and brainstem. In summary, this is the first report of a patient with both VPSPr 
and ALS, confirmed with PrP biochemistry, as well as light and electron microscopic 
TDP-43 immunohistochemistry.
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Neuropathologic profile of VPSPr-129M/V and ALS case. H&E shows balloon neurons in 
the superior temporal gyrus (a) and spongiform change in the caudate (b). H&E also 
revealed skein-like inclusions (black arrow) and Bunina bodies (green arrow) in the 
hypoglossal nucleus (c). PrP immunohistochemistry in the occipitotemporal gyrus reveals 
many prion plaques in the superficial cortical layers (d) and small dense plaques in the 
cerebellum (e). Ultrastructural examination of a prion plaque in the hippocampus (red 
arrows) reveals PrP immunopositive fibrils (f; blues arrows of gold particles).TDP-43 
immunohistochemistry in the medulla exhibits skein-like and Lewy-like inclusions in motor 
neurons of the hypoglossal nucleus (g) as well as pre-inclusions in the anterior horn cells 
(h). Ultrastructural examination of a skein-like cytoplasmic inclusions (red arrows) in the 
hypoglossal nucleus reveals TDP-43 immunopositive filaments coated with a granular 
material (f; blues arrows of gold particles). [bar = 20 μm in a-e; 10 μm in g; 8 μm in h; 2.5 
μm in i (large); 1 μm in f (large); 0.2 μm in f and i (small)]
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Detection and characterization of PrP. Immunoblot of total homogenates, treated with 
proteinase K, obtained from the frontal cortex of the present case and of the most common 
sporadic CJD subtypes, sCJD-MM1 and sCJD-VV2. Membranes were probed with the anti-
PrP monoclonal antibodies 3F4 (residues 109-112) and 1E4 (residues 97-108). PrP of the 
present case, detected by both Abs, showed the typical electrophoretic pattern of VPSPr-PrP. 
As expected in VPSPr, the most efficient immunoreactivity signal was obtained by 1E4, an 
antibody also known for its weak immunoreactivity to PrP-type1.
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